| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Controller & Pao
1 company
Eric Alejandro Miller last filed a Form 4 in October 2019, as Controller & Pao at ACAD. Eric Alejandro Miller's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 270 shares of ACAD. The ACAD filings lean toward selling, a net 33,259 shares.
Eric Alejandro Miller has 3 Form 4 filings on record from April 2019 to October 2019, all as Controller & Pao at Acadia Pharmaceuticals (ACAD), 2019.
The 12 reported transactions were 7 option exercises, 3 open-market sales and 2 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $1.3M.
The largest open-market sale was 33,112 shares of ACAD at an average $39.73 on September 11, 2019, about $1.3M.
Shares as reported in the last Form 4 for each company; the most recent is from October 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.